Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-17

Clinical Trial Update: Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is investigating the combination of fractional laser treatment with tirbanibulin ointment for basal cell carcinoma and squamous cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tirbanibulin ointment (tirbanibulin)

Snippet

Sponsor: Bruce Robinson, MD | Conditions: Keratinocyte Carcinoma, Basal Cell Carcinomas | Phase 1, Phase 2 | Status: RECRUITING